Navigation Links
Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week'
Date:12/4/2009

Case Western Reserve University researchers, from the School of Medicine's Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abuse, known as 4-hydroxyacids, are metabolized. The pathways were identified by a combination of metabolomics and mass isotopomer analysis. The findings shed new light on the mechanism of action of the drug of abuse gamma-hydroxybutyrate, also known as "the date rape drug." The manuscript published in the November 27th issue of the Journal of Biological Chemistry was named a "Paper of the Week." Such papers are chosen from the top one percent of all articles submitted to the prestigious peer-reviewed journal. This type of rare breakthrough sets the ground work for future discoveries.

This work was supported by a RoadMap grant from the National Institutes of Health, a grant from the National Institute of Environment Health Sciences, as well as by a grant from the Cleveland Mt. Sinai Health Care Foundation. The RoadMap grant funded the development of metabolomics at Case Western Reserve, as well as the acquisition of a top-of-the-line mass spectrometer. This instrument allowed this and multiple other studies to be conducted. The RoadMap initiative allowed a quantum jump in the development of metabolic research at the School of Medicine.

"Our finding will lead to studies that will increase the understanding of metabolic disturbances that occur during oxidative stress. The latter is part of the pathology of heart attacks, stroke, diabetes and inflammation," says Guo-Fang Zhang, Ph.D., Research Associate in the Department of Nutrition at Case Western Reserve School of Medicine. "We hope that the upcoming studies will lead to the design of new treatments that minimize the effects of oxidative stress."

"Paving a Catabolic Highway," an editorial about this landmark study concluded, "Overall, this study represents an exemplary prototype for any projects that aim to identify incomplete or unknown metabolic pathways."

"A combined effort of Case Western Reserve University and the Mt. Sinai Health Care Foundation since 1990 has lead to the building of this department's research program and the conception of this groundbreaking finding," says Henri Brunengraber, M.D., Ph.D., Senior Author, Professor, and Chair of the Department of Nutrition. "We plan to expand this project in close collaboration with Gregory P. Tochtrop, Ph.D., Assistant Professor in the Department of Chemistry. Dr. Tochtrop and his group have synthesized a number of carbon 13-labeled compounds which allowed the unraveling of the steps of the new pathways we discovered".


'/>"/>

Contact: Jessica Studeny
jessica.studeny@case.edu
216-368-4692
Case Western Reserve University
Source:Eurekalert

Related medicine news :

1. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
2. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
3. Evanston Northwestern Healthcare Wins Award For Patient Safety
4. Physician Team at Northwestern Memorial Performs Rare Oral Gallbladder Removal
5. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
6. UT Southwestern scientist receives NIH Directors New Innovator Award
7. UT Southwestern investigating hypothermic technique in treating pediatric head injuries
8. 2 UT Southwestern researchers elected to National Academy of Sciences Institute of Medicine
9. UT Southwestern researcher named Howard Hughes Medical Institute investigator
10. Nursing Scholarships Offered by Western Governors University for Masters Degree Programs
11. Northwestern Memorial Hospital Completes Move Into Its New Prentice Womens Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... New ... of ready-to-drink, high-protein beverages by helping beverage manufacturers more effectively manage protein costs. ... direct cost savings as well as more stable pricing over time. Now it’s ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a medical ... that it has received 510(k) clearance from the U.S. Food & Drug Administration ... Pro. , Both devices are stationary cycling systems that use MYOLYN’s patent-pending ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... collaboration, announces Mirroring360 Pro . This new addition to the Mirroring360 product ... for education and business. , Mirroring360 Pro enables educators, business professionals and individuals ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and funding ... randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... CFOs and HR decision-makers are preparing for how his administration could impact the ... provide insight into what changes are most likely to make it through Congress. ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: